Abstract
The purpose of the study was to evaluate the feasibility and effectiveness of direct porto-caval shunts in patients with Budd-Chiari syndrome (BCS) in whom there is no access to the hepatic veins during transjugular intrahepatic portosystemic shunt (TIPSS). We included six consecutive patients with fulminant/acute Budd-Chiari syndrome (mean age: 35 years) in whom a conventional TIPSS was not possible due to inaccessible hepatic veins. We performed a direct porto-caval shunt via a transhepatic approach. Patients were followed up by means of clinical examination, laboratory investigations, and Doppler ultrasound. TIPSS implantation from the inferior vena cava (IVC) was successful in all six patients (100%). The median transhepatic shunt length was 9 cm (8–10 cm). No procedure-related complications were observed in our patients. Early shunt occlusion occurred in three out of six patients (50%). In all three of these patients, the stent used to stabilize the shunt ended 1–2 cm before reaching the IVC. All occlusions were successfully recanalized. One of these patients developed recurrent early shunt as well as mesenteric and splenic vein occlusions. She died 7 days after TIPSS placement due to an unmanageable coagulation disorder. The remaining five patients were followed up by planned clinical examination and laboratory investigations (mean follow-up time was 15 months; patient 1 was followed up for 13 months, patient 2 for 14 months, patient 3 for 15 months, and patients 4 and 5 for 16 months) and all displayed a complete and durable resolution of liver failure and ascites without reintervention. In patients with acute liver failure originating from BCS and inaccessible hepatic veins, a direct transhepatic porto-caval shunt can be performed safely and effectively under ultrasound guidance. Future studies in larger patient groups should investigate if the patency of transcaval TIPSS with long transhepatic shunt segments is similar compared to conventional TIPSS via the hepatic vein.
Similar content being viewed by others
References
Menon KV, Shah V, Kamath PS (2004) The Budd-Chiari syndrome. N Engl J Med 5;350(6):578–585
Xu K, Feng B, Zhong H, et al. (2003) Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J (Engl) 116(4):609–615
Maddrey WC (1984) Hepatic vein thrombosis (Budd-Chiari syndrome). Hepatology. 4(1 Suppl):44S–46S
Kugelmas M (1998) Budd-Chiari syndrome. Treatment options and the value of liver transplantation. Hepatogastroenterology 45(23):1381–1386
Faust TW (1999) Budd-Chiari Syndrome. Curr Treat Options Gastroenterol 2(6):491–504
Kavanagh PM, Roberts J, Gibney R, et al. (2004) Acute Budd-Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 19(10):1135–1139
Rössle M, Siegerstetter V, Huber M, et al. (1998) The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art. Liver 18(2):73–89
Valla DC (2002) Hepatic vein thrombosis. Semin Liver Dis 22:5–14
Dilawari JB, Bambery P, Chawla Y, et al. (1994) Hepatic outflow obstruction (Budd–Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Balt) 73(1):21–36
Valla J, Benhamou J (1999) Obstruction of the hepatic venous system. In: Bircher J, Benhamou J, McIntyre N, et al. (eds) Oxford Textbook of Clinical Hepatology, 2nd ed. Oxford: Oxford Medical Publication, pp 1469–1478
Reynolds T, Peters R (1975) Budd–Chiari syndrome. In: Schiff L (ed) Diseases of the Liver, 4th ed. Philadelphia: Lippincott, pp 1502–1510
Bismuth H, Sherlock DJ (1991) Portasystemic shunting versus liver transplantation for the Budd–Chiari syndrome. Ann Surg 214 (5):581–589
Mahmoud AE, Mendoza A, Meshikhes AN, et al. (1996) Clinical spectrum, investigations and treatment of Budd–Chiari syndrome. Q J Med 89(1):37–43
Klein AS, Cameron JL (1990) Diagnosis and management of the Budd–Chiari syndrome. Am J Surg 160(1):128–133
Orloff MJ, Daily PO, Orloff SL, et al. (2000) A 27-year experience with surgical treatment of Budd–Chiari syndrome. Ann Surg 232(3):340–352
Arroyo V, Gines P, Gerbes AL, et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164–176
Yang XL, Cheng TO, Chen CR, et al. (1996) Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol 28:1720–1724
Fisher NC, McCafferty I, Dolapci M, et al. (1999) Managing Budd-Chiari syndrome: A retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44:568–574
Saxon RR, Barton RE, Keller FS, et al. (1995) Prevention, detection, and treatment of TIPSS stenosis and occlusion. Semin Intervent Radiol 12:375–383
Latimer J, Bawa SM, Rees CJ, et al. (1998) Patency and reintervention rates during routine TIPSS surveillance. Cardiovasc Intervent Radiol 21:234–239
Ochs A, Sellinger M, Haag K, et al. (1993) TIPS in the treatment of Budd-Chiari syndrome. J Hepatol 18:217–225
Hastings GS, O’Connor DK, Pais SO (1996) TIPS placement as a bridge to liver transplantation in fulminant Budd-Chiari syndrome. J Vasc Intervent Radiol 7:616
Shresta R, Durham JD, Wachs M (1997) Use of TIPS as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. Am J Gastroenterol 92:2304–2306
Ganger DR, Klapman JB, McDonald V, et al. (1999) TIPS for Budd-Chiari syndrome or portal vein thrombosis. Am J Fenterol 94:603–608
Perelló A, García-Pagán JC, Gilabert R, et al. (2002) TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 35:132–138
Uhl M, Roth D, Riely C (1996) TIPS for Budd-Chiari syndrome. Dig Dis Sci 41:1494–1499
Michl P, Bilzer M, Waggershauser T, et al. (2000) Successful treatment of chronic; 32:516–520
Seki S, Sakaguchi H, Kobayashi S, et al. (2001) TIPS in combination with oral anticoagulation for Budd-Chiari syndrome. Hepatogastroenterology 49:1447–1449
Kavanagh PM, Roberts J, Gibney R, et al. (2004) Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol (10):1135–1139
Rössle M, Olschewski M, Siegerstetter V, et al. (2004) The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 135(4):394–403
Orloff MJ, Daily PO, Orloff SL, et al. (2000) A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 232:340–352
Slakey DP, Klein AS, Venbrux AC, et al. (2001) Budd-Chiari syndrome: Current management options. Ann Surg 233:522–527
McCarthy PM, VanHeerden JA, Adson MA, et al. (1985) The Budd-Chiari syndrome: Medical and surgical management of 30 patients. Arch Surg 120:657–662
Slakey D, Klein AS, Venbrux A, et al. (2001) Budd-Chiari syndrome: Current management options. Ann Surg 233:522–527
Hadengue A, Poliquin M, Vilgrain V, et al. (1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106(4):1042–1047
Valla D, Hadengue A, el Younsi M, et al. (1997) Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology 25(4):814–819
Srinivasan P, Rela M, Prachalias A, et al. (2002) Liver transplantation for Budd-Chiari syndrome. Transplantation 73:973–977
Barton RE, Rosch J, Saxon RR, et al. (1995) TIPSS: Short and long-term results: A survey of 1750 patients. Semin Intervent Radiol 12:364–367
Stanley AJ, Jalan R, Forrest EH, et al. (1996) Long-term follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: result in 130 patients. Gut 39:479–485
Boyer TD, Haskal ZJ (2005) American Association for the Study of Liver Diseases Practice Guidelines: The role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Intervent Radiol 16(5):615–629
Hernandez-Guerra M, Turnes J, Rubinstein P, et al. (2004) PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 40(5):1197–1202
Maleux G, Nevens F, Wilmer A, et al. (2004) Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol 14(10):1842–1850; Epub 2004 Jun 25
Bureau C, Garcia-Pagan JC, et al. (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: Results of a randomized study. Gastroenterology 126(2):469–475
Haskal ZJ (1999) Improved patency of transjugular intrahepatic portosystemic shunts in humans: Creation and revision with PTFE stent-grafts. Radiology 213(3):759–766
Nunez O, de la Cruz G, Molina J, et al. (2003) Interventional radiology, angioplasty and TIPS in Budd-Chiari sindrome. Gastroenterol Hepatol 26(8):461–464
Peltzer MY, Ring EJ, LaBerge JM, Haskal ZJ, Radosevich PM, Gordon RL. Treatment of Budd–Chiari syndrome with a transjugular intrahepatic portosystemic shunt. JVIR 4 (1993), pp. 263–267
Ringe B, Lang H, Oldhafer KJ, et al. (1995) Which is the best surgery for Budd-Chiari syndrome: Venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 21(5):1337–1344
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quateen, A., Pech, M., Berg, T. et al. Percutaneous Transjugular Direct Porto-caval Shunt in Patients with Budd-Chiari Syndrome. Cardiovasc Intervent Radiol 29, 565–570 (2006). https://doi.org/10.1007/s00270-005-0103-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-005-0103-3